Healthcare

AyuVis
Healthcare

AyuVis
View On Demand

AyuVis founder and CEO, Dr. Suchi Acharya, will discuss all the treatment applications for this new drug that has a global market potential to exceed $100B annually.

Sommetrics
Healthcare

Sommetrics
View On Demand

Sommetrics founder and CEO, Richard Rose, shares why aerSleep II is a significant improvement over CPAPs and how they intend to make inroads in the $6B sleep apnea market.

InflammX
Healthcare

InflammX
View On Demand

InflammX CEO, Dr. Brian Levy shares details of a very promising development in the treatment of two of the most common and devastating side effects of diabetes.

Assembly Biosciences
Healthcare

Assembly Biosciences
Coming January 24

Assembly Bio CEO, Dr. John McHutchison, presents the company’s three-tiered strategic approach to curing HBV and the major inflection points that are coming this year and next.

AltaScience
Healthcare

AltaScience
View On Demand

AltaSeal is a non-surgical solution to the multi-billion dollar permanent contraception market and is superior to the current standard of care. 

BrickellBio
Healthcare

BrickellBio
View On Demand

The BrickellBio leadership team has launched some of the most successful drugs on the market today including Cialis, Prozac, Cymbalta, Juvederm, and more.

Sigyn Therapeutics
Healthcare

Sigyn Therapeutics
View On Demand

How a properly designed blood purification device can perform functions that are beyond the reach of drugs and have broad applications for the treatment of pandemic viruses and beyond.

2022-01-15 Avior Bio
Healthcare

Avior Bio
Watch On Demand

Avior Bio is ready to enter Phase 2 Clinical Trials for its treatment for pruritis, a $1.3 billion market opportunity with a clear unmet need.

AyuVis
Healthcare

AyuVis
View On Demand

AyuVis founder and CEO, Dr. Suchi Acharya will discuss the dire need for their treatment and the rapid progress that’s being made in saving the lives of pre-term babies.

Inflammx
Healthcare

InflammX
View On Demand

InflammX CEO, Dr. Brian Levy discusses the opportunity to co-invest in the company and help improve the vision of people with Dry AMD and Diabetic Retinopathy.